IV-treated pulmonary exacerbations in the prior year: An important independent risk factor for future pulmonary exacerbation in cystic fibrosis. [electronic resource]
Producer: 20171218Description: 372-9 p. digitalISSN:- 1873-5010
- Administration, Intravenous
- Adolescent
- Adult
- Anti-Bacterial Agents -- administration & dosage
- Child
- Child, Preschool
- Cystic Fibrosis -- complications
- Episode of Care
- Female
- Humans
- Male
- Middle Aged
- Proportional Hazards Models
- Respiratory Tract Infections -- drug therapy
- Risk Assessment -- methods
- Risk Factors
- Symptom Flare Up
- United States -- epidemiology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.